FIELD: pharmaceutical industry, in particular treatment and prophylaxis of oncology diseases.
SUBSTANCE: claimed agent is based on flavolignans selected from silimarin isomers and phospholipids, wherein as silimarin isomers extract from Solybum marianum fruits in liposome form with particle size of 100-500 nm, containing not less than 10 % of extract from Solybum marianum fruits is used. Method for treatment and prophylaxis of oncology diseases includes administration of said agent to patient by injection or infusion.
EFFECT: agent having low biodegradability and high selectivity for effective treatment and prophylaxis of estrogen-dependent tumors and epidermal and mesenchyme origin tumors.
7 cl, 4 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
ANTITUMOR LIPOSOMAL PREPARATION WITH DIRECTED EFEFCT | 2005 |
|
RU2292898C1 |
COMPOSITION FOR THERAPY OF HEPATIC PATHOLOGIES AND ONCOLOGICAL DISEASES | 2008 |
|
RU2379046C1 |
COMPOSITION FOR TREATMENT AND PROPHYLAXIS OF ONCOLOGICAL DISEASE | 2005 |
|
RU2311917C2 |
ANGIOGENESIS INHIBITOR, ANTI-ANGIOGENIC PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR TREATMENT OF MALIGNANT NEOPLASM | 2005 |
|
RU2287341C1 |
USE OF FLAVONOLIGNANS FOR INHIBITION OF EXCESSIVE AND PATHOLOGICAL PROLIFERATION OF VESSEL ENDOTHELIUM | 2005 |
|
RU2291706C1 |
PREVENTIVE COMPOSITION BASED ON SUBSTANCES OF PHENOL NATURE | 2008 |
|
RU2354395C1 |
PROPHYLAXIS COMPOSITION BASED ON PHENOLIC SUBSTANCES AND PHOSPHOLIPIDS | 2006 |
|
RU2306945C1 |
SPOTTED MILK THISTLE-BASE BIOLOGICALLY ACTIVE SUPPLEMENT FOR DECREASING ALCOHOLIC DEPENDENCE | 2005 |
|
RU2274400C1 |
MEDICATION, POSSESSING HEPATOPROTECTIVE, DETOXICATING AND REGENERATING ACTION | 2007 |
|
RU2418601C2 |
MEDICATION FOR PREVENTING COLIBACTERIOSIS IN BIRDS | 2007 |
|
RU2355410C2 |
Authors
Dates
2006-09-20—Published
2005-03-29—Filed